1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow David Liebner, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Niraparib for the Treatment of Leiomyosarcoma Niraparib Tosylate Monohydrate - Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma | Phase 2 | Withdrawn | David Liebner, MD | 2023-12-01 | 2023-09-18 |
Leiomyosarcoma (1)
niraparib (1)